A Study to Evaluate the Effect of Venglustat Tablets on Left Ventricular Mass Index in Male and Female Adult Participants With Fabry Disease

Investigational Site Number : 1580001, Taipei

Investigational Site Number : 1580003, Taichung

Investigational Site Number : 2080001, Copenhagen

Investigational Site Number : 5780001, Bergen

Investigational Site Number : 0400001, Graz

Investigational Site Number : 2760003, Berlin

Maryam Banikazemi, MD- Site Number : 8400001, Hawthorne

Investigational Site Number : 3800001, Milan

Lysosomal and Rare Disorders Research and Treatment Center (LDRTC)- Site Number : 8400004, Fairfax

Investigational Site Number : 7240002, Madrid

Emory University School of Medicine - Atlanta- Site Number : 8400009, Atlanta

Investigational Site Number : 7920002, Istanbul

University of Alabama -The Kirklin Clinic- Site Number : 8400010, Birmingham

Investigational Site Number : 7240001, Pontevedra

Investigational Site Number : 3800004, Bologna

Investigational Site Number : 7920003, İzmit

Investigational Site Number : 4100002, Yangsan

Investigational Site Number : 2760005, Mainz

Ann & Robert H. Lurie Children's Hospital of Chicago- Site Number : 8400005, Chicago

Investigational Site Number : 2760004, Hochheim am Main

Renal Disease Research Institute- Site Number : 8400012, Dallas

Investigational Site Number : 3800002, Naples

Investigational Site Number : 3800003, Naples

University of Utah Health Hospital- Site Number : 8400006, Salt Lake City

University of California Los Angeles Medical Center- Site Number : 8400008, Los Angeles

Investigational Site Number : 2500001, Garches

Investigational Site Number : 2760001, Würzburg

Investigational Site Number : 1560002, Beijing

Investigational Site Number : 1560005, Beijing

Investigational Site Number : 1560003, Shanghai

Investigational Site Number : 1560007, Guangzhou

Investigational Site Number : 1560001, Chengdu

Investigational Site Number : 1240003, Calgary

Investigational Site Number : 1240006, Edmonton

Investigational Site Number : 1240002, Vancouver

Investigational Site Number : 1240005, Toronto

Investigational Site Number : 2030001, Prague

Investigational Site Number : 3000002, Athens

Investigational Site Number : 3000003, Athens

Investigational Site Number : 3000001, Heraklion

Investigational Site Number : 3920006, Sapporo

Investigational Site Number : 3920007, Kagoshima

Investigational Site Number : 3920003, Kagoshima

Investigational Site Number : 3920005, Kawasaki

Investigational Site Number : 3920002, Sendai

Investigational Site Number : 3920004, Fukuoka

Investigational Site Number : 3920001, Tokyo

Investigational Site Number : 5280001, Amsterdam

Investigational Site Number : 6160003, Lodz

Investigational Site Number : 6160001, Krakow

Investigational Site Number : 4100001, Seoul

Investigational Site Number : 7240003, Alicante

Investigational Site Number : 7920001, Ankara

Investigational Site Number : 8260001, London